Introduction
An elevated concentration of low density lipoprotein (LDL) in plasma is an important risk factor for the development and progression of atherosclerotic cardiovascular disease ( 1) . The liver plays a central role both in the regulation of plasma LDL concentrations and in the maintenance of whole body sterol balance (2) . Absorbed dietary cholesterol is transported to the liver in chylomicron remnants, and secretion of cholesterol into bile, either directly or after conversion to bile acids, is the only significant mechanism whereby cholesterol is removed from the body. In response to changes in cholesterol influx or efflux, the liver compensates by adjusting the rate of de novo cholesterol synthesis and, in some cases, the rate of receptor-dependent LDL uptake. Since the liver is the principal site of LDL catabolism, changes in hepatic LDL receptor activity generally produce reciprocal changes in circulating LDL concentrations.
Conversion of cholesterol to bile acids is the major regulated pathway whereby cholesterol is eliminated from the body. The first and rate-limiting step in the bile acid biosynthetic pathway is catalyzed by cholesterol 7a-hydroxylase (3) . While the mechanisms have not been completely defined, 7a-hydroxylase activity appears to be regulated principally at the level of gene expression in response to bile acids fluxing through the liver in the enterohepatic circulation (4, 5) . Bile acid sequestrants such as cholestyramine bind bile acids in the intestinal lumen, thereby preventing their reabsorption. Loss of bile acids from the enterohepatic circulation results in derepression of 7a-hydroxylase expression (6) (7) (8) (9) (10) and an increase in the rate of bile acid synthesis (9, 11) . The liver compensates for the accelerated loss of cholesterol by increasing the rate of de novo cholesterol synthesis and, if this is inadequate, by increasing the receptordependent uptake of LDL from plasma (10) , thereby lowering circulating LDL levels. Clinical interventions that interfere with the enterohepatic cycling of bile acids have been shown to reduce the risk of myocardial infarction and cardiovascular mortality (12, 13) . Unfortunately, tolerated doses of bile acid sequestrants have a relatively limited capacity to increase hepatic 7a-hydroxylase expression and, as a consequence, often have only modest cholesterol lowering activity.
These observations suggest that primary overexpression of a 7a-hydroxylase gene might exert a salutary effect on whole body sterol balance and on circulating LDL cholesterol levels. We (14) and others (15) (16) (17) (18) have observed previously that intravenous administration of recombinant adenovirus to animals is associated with preferential infection of the liver, and that adenovirus-mediated transfer of genes encoding apolipoprotein A-i (14) and the LDL receptor (15) (16) (17) results in transient overexpression of these proteins, producing significant alterations in circulating lipoprotein profiles. The current studies were undertaken to determine whether adenovirus-mediated transfer of a gene encoding 7a-hydroxylase would increase hepatic enzyme activity and bile acid synthesis and to examine the effects of primary overexpression of 7a-hydroxylase on lipoprotein metabolism in vivo. These studies show that infec-somal 7a-hydroxylase activity and produces a dose-dependent reduction in plasma total, LDL, and, to a lesser degree, HDL cholesterol levels, despite suppression of endogenous 7a-hydroxylase gene expression and a compensatory increase in de novo cholesterol synthesis by the liver.
Methods
Recombinant viruses. The recombinant adenovirus AdCMV7a was generated by homologous recombination in 293 cells (19) essentially as described previously (14) . A cDNA encoding rat 7a-hydroxylase (generously provided by Dr. David Russell at this institution) was inserted into pACCMVpLpA (20) , and the resulting plasmid (10 ug) was cotransfected into 293 cells with 5 tig of XbaI-digested AdSVtPA (a derivative of Addl309 carrying a human tissue plasminogen activator cDNA expressed from the SV40 early promoter) DNA by calcium phosphate coprecipitation using a glycerol shock to boost transfection efficiency. Homologous recombination between the pAC plasmid and the right 91% fragment of the viral genome resulted in the formation of a recombinant viral genome of packageable size in which the CMV7a fusion gene replaces the native adenovirus early region 1. Clonally derived recombinant viruses were isolated and propagated as described previously (14) and characterized by restriction analysis and Southern blotting of viral DNA prepared from productively infected 293 cells. Generation of the recombinant adenoviruses AdRR5, which lacks an inserted gene in the El position, AdCMVLuc, carrying a gene encoding firefly luciferase, and AdCMV~3gal, carrying a gene encoding a nuclear-localizing variant of Escherichia coli (-galactosidase, have been described elsewhere (15) .
Large scale production of recombinant adenovirus was performed as described previously (21) For administration of virus, animals were lightly anesthetized with diethyl ether, a femoral vein was exposed, and 0.5-1.5 ml of isotonic saline containing purified recombinant adenovirus was injected intravenously using a tuberculin syringe under direct visualization. Hemostasis was obtained by direct pressure, and the incision was closed with 3-0 1. Abbreviations used in this paper: HMG CoA, 3-hydroxy-3-methylglutaryl coenzyme A; pfu, plaque forming units.
silk. Animals were allowed to recover on a warming tray before being returned to cages where they were provided with food and water ad libitum. 148 animals were studied in this series of experiments, of which 84 were studied while being maintained on the chow diet as follows: control (n = 30); infected with an irrelevant virus (AdCMVLuc or AdCMVpgal: n = 12); infected with AdCMV7a (2 x 109 pfu: n = 5, 1 x 10'0 pfu: n = 18, 2 X 1010 pfu: n = 6); treated with cholestyramine (n = 9); and treated with both AdCMV7a and cholestyramine (n = 4). An additional 46 animals were studied after feeding a diet supplemented with triglyceride and cholesterol (Western-type diet) as follows: supplemented diet control (n = 12); treated with cholestyramine (n = 12); infected with an irrelevant virus (n = 6); infected with AdCMV7a (n = 12); and treated with both cholestyramine and AdCMV7a (n = 4). In addition, 12 animals were studied on a diet supplemented with triglyceride alone and 6 animals were studied after 3 d of food restriction.
In preliminary experiments, we observed that the effects of adenovirus-mediated transfer of a 7a-hydroxylase gene on enzyme activity and plasma cholesterol levels peaked 3-5 d after infection and began to decline within 7 d. Consequently, subsequent studies were performed in animals 3 d after infection with recombinant virus.
Detennination of hepatic 7a-hydroxylase activity. Hepatic 7a-hydroxylase activity was measured using an HPLC-spectrophotometric assay that quantifies the mass of 7a-hydroxycholesterol formed from endogenous microsomal cholesterol after enzymatic conversion to 7a-hydroxy-4-cholesten-3-one using cholesterol oxidase as described previously (22) .
Deterpnination of LDL uptake rates in vivo. Plasma was obtained from normocholesterolemic hamsters maintained on standard rodent chow (Wayne Lab-Blox) and from normocholesterolemic human donors. The LDL was isolated from plasma by preparative ultracentrifugation in the density range of 1.020-1.055 grams/ml. LDL was labeled with 125I-or 131I-tyramine cellobiose as described previously (23). The human LDL was also reductively methylated to completely eliminate its recognition by the LDL receptor (24). Total LDL uptake into each tissue was measured using homologous (normocholesterolemic hamster) LDL, and the receptor-independent component was determined using methylated human LDL. Receptor-dependent LDL uptake was taken as the difference between total and receptor-independent uptake. Rates of hepatic LDL uptake were measured using primed infusions of '25I-tyramine cellobiose-labeled LDL. The infusions were continued for 4 h at which time each animal was administered a bolus of 13'1I tyramine cellobiose-labeled LDL as a volume marker and killed 10 min later by exsanguination through the abdominal aorta. Tissue samples along with aliquots of plasma were assayed for radioactivity in a gamma counter (Packard Instrument Co., Downers Grove, IL). The amount of labeled LDL in the various tissues at 10 min ('3'I disintegrations per minute per gram of tissue divided by the specific activity of 1311 in plasma) and at 4 h ('25I disintegrations per minute per gram of tissue divided by the specific activity of '"I in plasma) was then calculated.
The increase in the tissue content of LDL cholesterol or LDL protein with time represents the rate of LDL uptake in micrograms of LDL cholesterol or LDL protein per hour per gram of tissue. Changes in hepatic receptor-dependent LDL uptake (defined as the rate of receptordependent LDL uptake in an experimental animal relative to the rate of receptor-dependent LDL uptake seen in control animals at the same plasma LDL concentration) were determined as described previously ( 10, 25) . The rate of LDL cholesterol entry into the plasma space (total LDL cholesterol transport) was determined as described previously (10, 25 Determination of mRNA levels. Hepatic 7a-hydroxylase, LDL receptor, 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase and glyceraldehyde-3-phosphate dehydrogenase mRNA levels were determined by nuclease protection as described previously (10, 27, 28) . Samples of hamster liver were homogenized in guanidinium isothiocyanate and RNA isolated by the method of Chomczynski and Sacchi (29) .
Total RNA (40 Iug) was hybridized with the 32P-labeled cDNA probes simultaneously at 480C overnight. Unhybridized probe, present in excess relative to the amount of specific mRNA, was then digested with 20 U of Mung bean nuclease (GIBCO-BRL, Gaithersburg, MD). The mRNAprotected 32P-labeled probes were separated on 7 M urea, 6% polyacrylamide gels together with 32P-labeled MspI-digested pBR322 size standards. The radioactivity in each band, corrected for background radioactivity, was determined using an isotopic imaging system (Ambis, Inc., San Diego, CA).
Species-specific single-stranded 32P-labeled probes for 7a-hydroxylase were synthesized by oligonucleotide primed synthesis from M13 subclones as described previously (10, 28, 30) . The rat probe was prepared from a subclone of a BamHI-XbaI fragment of the rat 7a-hydroxylase cDNA spanning nucleotides 1216-1468. The template cDNA fragment for the hamster specific probe was obtained by reverse transcription-PCR using hamster liver RNA and oligonucleotide primers that span nucleotides 337-577 as described (10) . Within these regions, the rat and hamster cDNA sequences differ at 35/252 and 17/ 240 nucleotides, respectively. Probes for HMG CoA reductase and the LDL receptor were prepared as described previously (10, 28) .
Determination of bile acid pool size and composition. The liver, gallbladder, and small intestine were harvested en block from control and AdCMV7a-infected hamsters, placed in a 400-ml beaker with Determination of liver and plasma cholesterol. Hepatic cholesterol was quantified by capillary gas-liquid chromatography. Microsomal unesterified cholesterol was quantified by HPLC. The cholesterol content of plasma was determined using an enzymatic assay kit (Boehringer Mannheim Corp., Indianapolis, IN). Cholesterol distribution in plasma was determined by gel filtration chromatography using a Superose-6 column (Sigma Chemical Co., St. Louis, MO) as described previously (10) . Equal amounts of plasma were pooled from identically treated control or treated animals and applied to the column; 2-ml aliquots were collected and assayed for cholesterol using the enzymatic assay.
Data analysis. Because of the large quantities required, several batches of recombinant viruses were used in these experiments. The data presented in each case reflect results from animals treated with a single virus stock. Data obtained from repeated experiments in which animals were treated similarly but with different batches of virus, or instrumented at different times, were not pooled for statistical analysis.
Data are presented as mean± 1 SD. Differences between treatments were examined using ANOVA and the Scheffe post-hoc test (3 1 ), with P < 0.05 considered significant.
Results
To determine whether animals infected with a recombinant adenovirus encoding cholesterol 7a-hydroxylase would express the transgene in liver, Syrian hamsters were administered 1 or 2 x 10 10 pfu of control virus or AdCMV7a by intravenous injection. Total RNA was prepared from livers harvested 3 d after infection and assayed for 7a-hydroxylase mRNA in a nuclease protection assay using 32P-labeled cDNA probes specific for hamster or rat 7a-hydroxylase. (1 x 1010 pfu). In this assay, the RNA-protected hamster 7a-hydroxylase probe is 240 nucleotides. The RNA-protected rat probe is 252 nucleotides and migrates as a doublet, as observed previously in assays using native rat liver RNA to protect this probe (30) .
RNA isolated from hamsters infected with control virus protected the hamster-specific 7a-hydroxylase probe but did not protect the rat-specific 7a-hydroxylase probe, which contains 35 nucleotide mismatches compared with the corresponding region of the hamster cDNA. In contrast, RNA purified from the livers of hamsters infected with recombinant virus encoding rat 7a-hydroxylase expressed transgene (rat) -specific mRNA (reflected in protection of the rat probe in a pattern identical to that observed previously using native rat liver RNA), while expression of mRNA from the native (hamster) gene was suppressed. Based on the length and specific activity of the hamster and rat probes, it could be estimated that administration of 1 total plasma cholesterol levels remained unchanged in animals administered control virus over the same dose range. In these experiments, a strong inverse correlation was observed between plasma cholesterol levels and hepatic microsomal 7a-hydroxylase activity (r2 = 0.67, P < 0.001).
Occasional animals (2/6) infected with the highest dose of virus demonstrated poor food consumption and some weight loss over the 3-4 d after infection. Data from animals that lost > 2% (3 -4 grams) body weight were excluded, and subsequent experiments were performed using 1 x 1010 pfu, a dose not associated with changes in food consumption or body weight. Nevertheless, a group of uninfected control animals was fasted for a similar period to exclude the possibility that partial fasting was responsible for the observed effect on plasma cholesterol levels. The fasted control animals lost > 10% of their body weight; however, plasma cholesterol fell by only 12% and hepatic 7a-hydroxylase activity and mRNA fell by 22 and 20%, respectively. To exclude a nonspecific effect of adenovirus infection, additional control animals were infected with 1-2 x 1010 pfu of AdCMVLuc or AdCMV,6gal. Plasma cholesterol levels 3 d after infection in these animals were slightly elevated (not statistically significant) compared with uninfected control animals, consistent with our prior observations in mice that infection with recombinant adenovirus per se does not significantly alter total plasma cholesterol levels ( 14) .
The large decrease in total plasma cholesterol observed in AdCMV7a-infected animals reflected reductions in cholesterol carried in both the LDL and HDL fractions. Fig. 3 fected with AdCMV7a compared with animals infected with control virus. HDL cholesterol levels were also reduced in animals infected with AdCMV7a, but to a lesser degree. Compared with uninfected controls, infection with control virus (AdCMVLuc) had no effect or slightly increased LDL and HDL cholesterol levels. Since LDL is the principal atherogenic lipoprotein in plasma, studies were carried out to investigate the mechanisms responsible for its decline. The concentration of LDL cholesterol in plasma is determined by the rate at which LDL cholesterol enters the plasma space (total LDL cholesterol transport), relative to the rate at which LDL cholesterol is removed from plasma, primarily by receptor-mediated clearance of LDL particles in the liver. Rates of LDL cholesterol entry into plasma (total LDL cholesterol transport) and hepatic receptor-dependent LDL uptake were determined 3 d after infection with 1 X 1010 pfu AdCMV7a. As shown in Fig. 4 , overexpression of hepatic 7a-hydroxylase had no effect on hepatic receptordependent LDL uptake in animals maintained on a very-lowcholesterol, low-fat diet. As shown at the bottom of Fig. 4 slightly higher (31%) than the mean of the uninfected control animals-a difference that did not achieve statistical significance (data not shown). Consistent with the effect of overexpression of 7a-hydroxylase on hepatic cholesterol synthesis, HMG CoA reductase mRNA levels were increased in the livers of AdCMV7a-infected animals when compared with animals infected with a control virus (as illustrated in Fig. 1 ). As also shown in Fig. 5 , overexpression of hepatic 7a-hydroxylase had no effect on the total cholesterol content of the liver in animals maintained on a very-low-cholesterol, low-fat diet. Similarly, the cholesterol content of hepatic microsomes was not reduced in AdCMV7a-infected animals.
Newly synthesized bile acids join a large enterohepatic pool of bile acids that circulates several times a day between the liver and intestine. To determine if primary overexpression of 7a-hydroxylase alters the enterohepatic pool, the size and composition of the pool was determined 3 d after the administration of 1 x 1010 pfu AdCMV7a. As shown in Table I , transient overexpression of hepatic 7a-hydroxylase led to expansion of the enterohepatic pool of bile acids by 53%. In contrast, the bile acid sequestrant cholestyramine reduced the size of the enterohepatic pool (and prevented the increase in pool size caused by primary overexpression of 7a-hydroxylase). As also shown in Table I , primary overexpression of 7a-hydroxylase had no effect on the composition of the enterohepatic pool, suggesting that distal steps in the bile acid biosynthetic pathway were not rate limiting even under circumstances in which 7a-hydroxylase was markedly overexpressed. As described previously, cholestyramine increased the proportion of cholic acid in the enterohepatic pool at the expense of chenodeoxycholic acid (32) .
These initial studies concerning the metabolic consequences of primary overexpression of 7a-hydroxylase were carried out in animals fed a very-low-cholesterol, low-fat (chow) diet. Because the mechanisms regulating cholesterol homeostasis in the liver are sensitive to dietary cholesterol and triglyceride intake, additional experiments were conducted in animals maintained on a diet intended to simulate that of Western humans. For these experiments, the control diet was supplemented with triglyceride (10% coconut oil and 5% safflower oil by weight) and small amounts of cholesterol (0.1% by weight). Animals were maintained on this diet for 6 wk at which time plasma cholesterol levels stabilized in the 300-350 mg/dl range with LDL cholesterol concentrations of 150-200 mg/dl. Basal levels of 7a-hydroxylase activity were 50% lower in animals fed the Western-type diet than in animals fed the low-fat control diet (31±7 vs. 66±17 pmol/h per mg). The reduced basal level of 7a-hydroxylase activity in animals maintained on the Western-type diet was apparently related to the high triglyceride content of the diet. Thus, supplementing the control diet with triglyceride alone also reduced 7a-hydroxylase activity by 50%, whereas supplementing the control diet with cholesterol alone had no significant effect (our unpublished observation). In any event, the fold increase in hepatic 7a-hydroxylase activity produced by AdCMV7a infection was greater in animals fed the Western-type diet than in animals maintained on the low-fat control diet (due to the lower basal level of activity in animals fed the Western-type diet). Animals Fig. 7 . Changes in LDL transport in response to the Westerntype diet reflected a complex interaction between the triglyceride and cholesterol present in the diet. As described previously (33) , supplementing the very-low-cholesterol, low-fat diet with triglyceride alone (Fig. 7, dashed bars) Equal aliquots of plasma were pooled from three animals in each group. The pooled plasma was fractionated by Superose-6 chromatography, and the eluted fractions were assayed for cholesterol. The retention times for hamster VLDL (d < 1.006 grams/ml), LDL (d = 1.020-1.055 grams/ml), and HDL (d = 1.063-1.21 grams/ml) are indicated.
of LDL cholesterol entry into plasma (total LDL cholesterol transport) and the rate of receptor-dependent LDL uptake by the liver, resulting in little net change in plasma LDL cholesterol concentrations (mean 39 mg/dl vs. 30 mg/dl in controls). The addition of cholesterol to the triglyceride-enriched diet (Fig. 7 , solid bars) further increased the rate of LDL cholesterol entry into plasma (total LDL cholesterol transport), but in addition suppressed hepatic receptor-dependent LDL uptake causing a large increase in plasma LDL cholesterol concentrations (to 181 mg/dl). In animals maintained on the triglyceride and cholesterol supplemented (Western-type) diet, primary overexpression of 7a-hydroxylase (Fig. 7, shaded In contrast, administration of 1 x 1010 pfu of control virus (AdCMVLuc or AdCMVJ3gal) to four animals maintained on the Western-type diet had no effect on hepatic receptor-dependent LDL uptake, total LDL cholesterol transport, or plasma LDL cholesterol concentrations (data not shown).
In these experiments, changes in hepatic receptor-dependent LDL uptake paralleled changes in hepatic LDL receptor mRNA levels. Expression of mRNA encoding the LDL receptor was suppressed in the livers of animals fed the Western-type diet. 3 d after administration of AdCMV7a to animals maintained on this diet, expression of LDL receptor mRNA was restored to levels similar to those observed in animals maintained on the very-low-cholesterol, low-fat control diet (data not shown). Thus, while primary overexpression of hepatic 7a-hydroxylase did not upregulate the LDL receptor pathway in animals fed a very-low-cholesterol, low-fat diet, it did restore LDL receptor mRNA levels and hepatic receptor-dependent LDL uptake in animals fed a Western-type diet.
The effects of overexpression of 7a-hydroxylase on the cholesterol content of the liver and the rate of cholesterol synthesis in animals maintained on a Western-type diet are shown in Fig.  8 . The cholesterol content of the liver was much higher in animals maintained on the Western-type diet (18 mg/gram) than in animals maintained on the very-low-cholesterol, lowfat control diet (3.2 mg/gram). Consistent with the elevation in hepatic cholesterol stores, the rate of de novo cholesterol synthesis was suppressed by 70% in animals fed the Westerntype diet. 3 d after the administration of AdCMV7a to animals maintained on this diet, hepatic cholesterol levels were insignificantly lower (14 vs. 18 mg/gram). Despite the elevated hepatic cholesterol content, the rate of hepatic cholesterol synthesis returned to near normal levels 3 d after the administration of AdCMV7a. Primary overexpression of 7a-hydroxylase was associated with expansion of the enterohepatic bile acid pool. Since expansion of the bile acid pool by oral administration of bile acids has been shown to enhance cholesterol absorption (34), a similar effect might limit the efficacy of primary overexpression of 7a-hydroxylase in reducing plasma cholesterol levels. If so, administration of a bile acid sequestrant might be expected to enhance the hypocholesterolemic activity associated with transfer of a 7a-hydroxylase gene. To investigate this possibility, we performed additional experiments in which animals maintained on control or Western-type diets were treated with AdCMV7a, cholestyramine, or both. In these studies, administration of AdCMV7a increased hepatic 7a-hydroxylase activity by 10-12-fold in animals fed the control diet and by 20-25-fold in animals maintained on the Western-type diet (due to the lower basal level of 7a-hydroxylase activity in animals fed the Western-type diet). As expected, addition of 1% cholestyramine had no effect on hepatic mRNA levels for the transgene, which is expressed from a strong viral promoter not responsive to sterols, nor did cholestyramine significantly upregulate the (suppressed) levels of mRNA encoding native (hamster) 7a-hydroxylase in animals greatly overexpressing the transgene (data not shown). As a consequence, the addition of cholestyramine did not further increase hepatic 7a-hydroxylase activity above levels obtained after infection with AdCMV7a alone. Nonetheless, cholestyramine reduced the size of the enterohepatic bile acid pool and augmented the cholesterol-lowering effects of AdCMV7a, as shown in Fig. 9 . Thus, cholestyramine lowered plasma total and LDL cholesterol concentrations in animals infected with AdCMV7a, independent of any effects on hepatic 7a-hydroxylase activity. One possible explanation for these observations is that expansion of the enterohepatic pool of bile acids in animals infected with AdCMV7a resulted in enhanced cholesterol absorption-an effect prevented by cholestyramine.
Discussion
These studies demonstrate that animals infected with recombinant adenovirus carrying a gene encoding cholesterol 7a-hydroxylase transiently express the transgene at high levels in liver. Primary overexpression of hepatic 7a-hydroxylase was associated with a dose-dependent increase in microsomal 7a-hydroxylase activity, a reciprocal decline in plasma total and LDL cholesterol levels, and a more modest decline in HDL cholesterol. The marked reduction in plasma LDL cholesterol concentrations was attributable to a reduction in the rate of LDL cholesterol entry into plasma (total LDL cholesterol transport), and, in animals maintained on a Western-type diet, to restoration of receptor-dependent LDL uptake by the liver. The observation that primary overexpression of hepatic 7a-hydroxylase is sufficient to substantially lower plasma cholesterol levels, even in the absence of interventions that interfere with the enterohepatic cycling of bile acids, suggests that 7a-hydroxylase may be an attractive molecular target for strategies aimed at reducing cardiovascular risk. The magnitude of the hypocholesterolemic effect obtained after transient in vivo transfer of a cholesterol 7a-hydroxylase gene and the observation of additive effects of gene transfer and a bile acid sequestering resin suggest that genebased approaches might have efficacy complementary to conventional therapy, if sustained overexpression could be safely achieved.
More immediately, these studies provide some insights into the mechanisms regulating hepatic sterol balance and LDL transport. Our observations are consistent with prior work indicating that 7a-hydroxylase activity is regulated primarily at the level of gene transcription (5, 8, (35) (36) (37) (38) (39) and that bile acid(s) is(are) the principal regulatory effector(s) in the hamster (40) . Hepatic 7a-hydroxylase activity increased severalfold after AdCMV7a infection and the enterohepatic pool of bile acids increased by -50%. These changes were associated with suppression of endogenous 7a-hydroxylase mRNA levels similar to that observed after expansion of the enterohepatic pool by oral administration of bile acids (10) . Despite expansion of the bile acid pool and suppression of the endogenous gene, we observed roughly parallel increases in hepatic 7a-hydroxylase mRNA content and enzyme activity in infected animals, suggesting that in the hamster under these experimental conditions 7a-hydroxylase activity is not substantially regulated by bile acids through posttranslational mechanisms. Unlike the rat, hamster 7a-hydroxylase expression appears not to be regulated by cholesterol (substrate) availability (40) .
The relationship between the level of hepatic 7a-hydroxylase expression and circulating LDL concentrations is complex. In animals maintained on a very-low-cholesterol, low-fat diet, the decrease in plasma LDL cholesterol concentrations resulted entirely from a reduction in the rate of LDL cholesterol entry into plasma (total LDL cholesterol transport). Hepatic receptordependent LDL uptake and LDL receptor mRNA levels were not increased above levels observed in untreated control animals. How overexpression of 7a-hydroxylase reduces the rate of LDL cholesterol entry into the plasma space is not known. LDL are formed in plasma during the metabolism of VLDL (41) . VLDL, in turn, are triglyceride-rich particles secreted by the liver that function primarily to move triglyceride from the liver to peripheral sites of utilization and storage. After hydrolysis of VLDL triglyceride in extrahepatic tissues, the particle is either returned to the liver as a VLDL remnant or further metabolized to LDL. Thus, the rate of LDL formation is dependent on the proportion of VLDL that is converted into LDL as well as the rate of VLDL secretion. While we observed that plasma VLDL cholesterol concentrations were not altered by overexpression of 7a-hydroxylase, the (42, 43) . In animals fed the control diet, overexpression of 7a-hydroxylase increased the rate of hepatic cholesterol synthesis by nearly threefold but did not reduce hepatic total or esterified cholesterol or the unesterified cholesterol content of microsomes. Similarly, in animals maintained on the Western-type diet, overexpression of 7a-hydroxylase completely reversed the suppressive effect of dietary cholesterol on HMG CoA reductase and the LDL receptor pathway despite the fact that microsomal unesterified cholesterol levels were not reduced and hepatic total and esterified cholesterol levels, although falling, were still markedly elevated. Several possibilities might account for these observations. First, it is likely that the regulatory pool of unesterified cholesterol is small relative to the large amount of structural cholesterol present in the cell, making any changes in the size of the regulatory pool difficult to detect. Secondly, in these transient overexpression experiments, a new steady state was likely not achieved by 3 d, particularly in animals maintained on the cholesterol-enriched diet. It is possible, therefore, that the pool of hepatic unesterified sterol regulating HMG CoA reductase and the LDL receptor pathway is not in rapid equilibrium with the large pool of storage (esterified) cholesterol under these experimental conditions. Finally, the link between 7a-hydroxylase and other sterol-regulated genes may be through a molecule other than cholesterol. For example, it has been suggested that overexpression of 7a-hydroxylase inactivates oxysterols that may be potent repressors of HMG CoA reductase and LDL receptor gene expression. In any case, our observations in vivo are consistent with recent studies in COS cells transfected with a cDNA encoding 7a-hydroxylase, which showed that expression of 7a-hydroxylase increased HMG CoA reductase activity without reducing cellular cholesterol levels (44) , and with previous studies in Chinese hamster ovary cells where expression of 7a-hydroxylase was associated with resistance of the LDL receptor to suppression by cholesterol (45) .
Hepatic 7a-hydroxylase is induced by interventions that deplete the bile acid pool (such as bile diversion, ileal resection, or administration of bile acid sequestrants) and suppressed by interventions that expand the pool (such as bile acid administration). Under these conditions, changes in 7a-hydroxylase expression are always accompanied by parallel changes in HMG CoA reductase activity. The two enzymes would appear to be metabolically linked by cholesterol, which is the substrate for 7a-hydroxylase and exerts tight feedback control on the expression of HMG CoA reductase. Nevertheless , it has been difficult to rule out the theoretical possibility that bile acids may directly inhibit HMG CoA reductase expression. In these studies, overexpression of an exogenous 7a-hydroxylase gene resulted in expansion of the bile acid pool and suppression of endogenous 7a-hydroxylase gene expression similar to that seen in hamsters fed large amounts of bile acids (10) . Under these conditions, however, HMG CoA reductase mRNA and the rate of cholesterol synthesis were upregulated (rather than repressed as seen with bile acid feeding), strongly suggesting that bile acids exert little, if any, direct inhibitory effect on HMG CoA reductase.
Dietary cholesterol raises plasma total and LDL cholesterol concentrations; however, the response to a given intake of cholesterol varies enormously among different animal species and even among individuals of the same species (46) . The liver plays a key role in adaptation to a high cholesterol diet since it is not only the recipient of absorbed dietary cholesterol but is also the major site through which cholesterol is eliminated from the body (2) . In this regard, the level of expression of hepatic 7a-hydroxylase appears to be a critical determinant of responsiveness to dietary cholesterol. On a low cholesterol diet, rapid conversion of cholesterol to bile acids necessitates a high rate of hepatic cholesterol synthesis to provide substrate. High basal rates of hepatic cholesterol synthesis, in turn, allow the liver to compensate for large inputs of dietary cholesterol simply by downregulating de novo synthesis. Hamsters express low basal levels of 7a-hydroxylase and are more responsive to the cholesterolemic effects of dietary cholesterol than species such as rats and mice that exhibit far higher levels of basal 7a-hydroxylase expression (40) . In addition, hamster 7a-hydroxylase is not significantly upregulated in response to dietary cholesterol (40) , in contrast to the situation in species highly resistant to dietary cholesterol such as the rat and mouse. In the current studies, hepatic 7a-hydroxylase activity in the hamster was raised (by primary overexpression) to levels ordinarily observed in rats and mice and produced resistance to dietary cholesterol similar to that of rats and mice. Available data suggest that most humans resemble the hamster, with relatively low basal levels of hepatic bile acid and cholesterol synthesis and modest sensitivity to the cholesterolemic effects of dietary cholesterol (2, 46) . These observations and those of the current study, that direct augmentation of hepatic 7a-hydroxylase expression can restore hepatic LDL receptor activity and normalize serum cholesterol levels in hamsters fed a high-fat, highcholesterol diet, suggest that primary manipulation of 7a-hydroxylase gene expression may have potential as a therapeutic target for the management of clinical hypercholesterolemia.
Inflammatory mediators (produced in response to infection or inflammatory disease) may induce disturbances in lipid and lipoprotein metabolism, and in the hamster endotoxin and various inflammatory mediators raise plasma total and LDL cholesterol concentrations (47, 48) . In addition, these agents induce HMG CoA reductase expression and increase cholesterol synthesis rates in the liver. We did not examine the effect of adenovirus vectors on the release or levels of specific cytokines. Nevertheless, several lines of evidence suggest that the observed effects on sterol and lipoprotein metabolism were not nonspecific effects of viral infection or of the immune response to infection. First, the effects of AdCMV7a were compared with control viruses expressing irrelevant genes (luciferase orfgalactosidase). Administration of these control viruses at the highest doses tended to raise serum LDL levels and increase the rate of hepatic cholesterol synthesis; however, both effects were small and statistically insignificant. In addition, overexpression of 7a-hydroxylase markedly lowered serum LDL levels, whereas the dominant effect of the inflammatory mediators studied to date is, as noted above, to raise serum LDL concentrations in the hamster.
Like prior studies targeting expression of the LDL receptor (15) (16) (17) and apolipoprotein A-1 (14) , this study demonstrates the utility of in vivo gene transfer as an experimental tool for physiologic studies of lipoprotein metabolism. In addition, because the biochemical effects of transient overexpression of cholesterol 7a-hydroxylase are directionally ones which might exert a salutary effect on the development and/or progression of atherosclerosis, these experiments suggest one potential molecular target for gene-based therapeutic interventions to reduce cardiovascular risk. Before the potential of gene transfer to affect the course of atherosclerosis can be assessed, however, effective strategies to achieve sustained, high level expression of the transferred gene must be developed. The recent identification of host immune responses to expressed viral gene products as an important factor limiting the duration of foreign gene expression after adenovirus-mediated gene transfer, and the finding of sustained expression after transfer of a reporter gene into the livers of mice using a variant adenovirus vector carrying a ts mutation in the E2A region (49) suggest one potentially promising approach.
